#India’s largest Secondary Care Surgery provider

[latestmarketresearchnews]

Urinary Catheters Industry Insights and Trends Report by 2030

The global urinary catheters market was valued at USD 5.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. This growth is driven by a rising number of patients affected by urinary tract infections (UTIs), urethral blockages, tumors in the urinary tract or reproductive organs, and a rapidly increasing elderly population. Urinary catheters are flexible tubes used to drain urine from the bladder, essential for patients who suffer from urinary incontinence, urinary retention, prostate surgery recovery, or other conditions, including spinal cord injuries, multiple sclerosis, or dementia. These catheters are made from materials such as plastic, rubber, and silicon, chosen for their durability and flexibility.

The COVID-19 pandemic has had a notable impact on the demand for urinary catheters. During the pandemic, the use of both urinary catheters and central lines increased as hospitals focused on maintaining infection control and managing patient care for critically ill patients. According to the National Center for Biotechnology Information, the Standardized Utilization Ratio (SUR) of urinary catheters rose by 7.4%, from 0.79 pre-pandemic to 0.84 during the pandemic. This increased utilization is expected to contribute to market growth. Furthermore, the pandemic highlighted the importance of infection prevention, driving manufacturers to develop enhanced products, such as coated urinary catheters with built-in temperature monitoring, aimed at reducing secondary infections in ICU patients. For instance, in February 2021, Health Canada approved Bactiguard’s urine catheter with a temperature sensor for infection prevention, fast-tracking the approval due to COVID-19’s impact on infection rates among ICU patients.

Gather more insights about the market drivers, restrains and growth of the Urinary Catheters Market

Additionally, the pandemic has accelerated the adoption of teleconsultation services for patients with urological conditions, supported by government initiatives in various countries to reduce the risk of COVID-19 transmission. This shift to virtual healthcare has allowed patients to receive consultations without visiting hospitals, further expanding the market. Companies are also launching platforms to provide remote counseling and guidance for patients unable to access in-person care. For example, Nobel Hygiene, an adult diaper brand in India, launched an awareness campaign during lockdowns to help families identify symptoms of urinary incontinence, offering telemedicine support for managing the condition. Such campaigns highlight the rising need for urinary catheters and related products, particularly for elderly patients who suffer from urinary incontinence, thereby boosting market demand over the forecast period.

Application Segmentation Insights:

The Urinary Incontinence (UI) segment was the largest market segment in 2022, capturing over 37.1% of revenue share. Urinary incontinence is prevalent globally, affecting one-third of the population, with a higher incidence in women. This condition is a significant concern for long-term care facilities, as it frequently leads to the admission of elderly individuals into institutional care settings. Factors such as age-related changes in the urinary tract, UTIs, and other health conditions like diabetes, stroke, cancer, and mobility impairments contribute to bladder incontinence. Women, in particular, are more likely to experience stress and urge incontinence. According to the Urology Care Foundation, overactive bladder affects approximately 33 million people in the U.S., with a substantial portion of men and women experiencing UI.

The Benign Prostate Hyperplasia (BPH) and prostate surgeries segment is expected to experience the fastest growth during the forecast period. BPH, also known as an enlarged prostate, is a common condition in men aged 50 and older, leading to uncomfortable urinary symptoms and blockage of urine flow. Treatment for BPH often involves minimally invasive surgeries, which help relieve urinary retention caused by the condition. The increase in awareness about BPH and its impact on patients’ quality of life is contributing to this segment's growth. In addition, statistics from the National Spinal Cord Injury Statistical Center show that approximately 294,000 individuals in the U.S. live with spinal cord injuries, with around 17,810 new cases diagnosed annually. These injuries frequently lead to urinary complications, further driving the need for urinary catheters within this segment.

Overall, the market for urinary catheters is on a steady growth trajectory, driven by the increasing prevalence of urinary conditions, advances in telemedicine, and the critical role of these devices in infection prevention. With ongoing developments in catheter technology and rising awareness of conditions like UI and BPH, the market is poised for continued expansion, particularly in segments related to elderly care and chronic urinary issues.

Order a free sample PDF of the Urinary Catheters Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Urinary Catheters Industry Growth Analysis, Trends Forecast by Regions and Types to 2030

The global urinary catheters market was valued at USD 5.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. This growth is driven by a rising number of patients affected by urinary tract infections (UTIs), urethral blockages, tumors in the urinary tract or reproductive organs, and a rapidly increasing elderly population. Urinary catheters are flexible tubes used to drain urine from the bladder, essential for patients who suffer from urinary incontinence, urinary retention, prostate surgery recovery, or other conditions, including spinal cord injuries, multiple sclerosis, or dementia. These catheters are made from materials such as plastic, rubber, and silicon, chosen for their durability and flexibility.

The COVID-19 pandemic has had a notable impact on the demand for urinary catheters. During the pandemic, the use of both urinary catheters and central lines increased as hospitals focused on maintaining infection control and managing patient care for critically ill patients. According to the National Center for Biotechnology Information, the Standardized Utilization Ratio (SUR) of urinary catheters rose by 7.4%, from 0.79 pre-pandemic to 0.84 during the pandemic. This increased utilization is expected to contribute to market growth. Furthermore, the pandemic highlighted the importance of infection prevention, driving manufacturers to develop enhanced products, such as coated urinary catheters with built-in temperature monitoring, aimed at reducing secondary infections in ICU patients. For instance, in February 2021, Health Canada approved Bactiguard’s urine catheter with a temperature sensor for infection prevention, fast-tracking the approval due to COVID-19’s impact on infection rates among ICU patients.

Gather more insights about the market drivers, restrains and growth of the Urinary Catheters Market

Additionally, the pandemic has accelerated the adoption of teleconsultation services for patients with urological conditions, supported by government initiatives in various countries to reduce the risk of COVID-19 transmission. This shift to virtual healthcare has allowed patients to receive consultations without visiting hospitals, further expanding the market. Companies are also launching platforms to provide remote counseling and guidance for patients unable to access in-person care. For example, Nobel Hygiene, an adult diaper brand in India, launched an awareness campaign during lockdowns to help families identify symptoms of urinary incontinence, offering telemedicine support for managing the condition. Such campaigns highlight the rising need for urinary catheters and related products, particularly for elderly patients who suffer from urinary incontinence, thereby boosting market demand over the forecast period.

Application Segmentation Insights:

The Urinary Incontinence (UI) segment was the largest market segment in 2022, capturing over 37.1% of revenue share. Urinary incontinence is prevalent globally, affecting one-third of the population, with a higher incidence in women. This condition is a significant concern for long-term care facilities, as it frequently leads to the admission of elderly individuals into institutional care settings. Factors such as age-related changes in the urinary tract, UTIs, and other health conditions like diabetes, stroke, cancer, and mobility impairments contribute to bladder incontinence. Women, in particular, are more likely to experience stress and urge incontinence. According to the Urology Care Foundation, overactive bladder affects approximately 33 million people in the U.S., with a substantial portion of men and women experiencing UI.

The Benign Prostate Hyperplasia (BPH) and prostate surgeries segment is expected to experience the fastest growth during the forecast period. BPH, also known as an enlarged prostate, is a common condition in men aged 50 and older, leading to uncomfortable urinary symptoms and blockage of urine flow. Treatment for BPH often involves minimally invasive surgeries, which help relieve urinary retention caused by the condition. The increase in awareness about BPH and its impact on patients’ quality of life is contributing to this segment's growth. In addition, statistics from the National Spinal Cord Injury Statistical Center show that approximately 294,000 individuals in the U.S. live with spinal cord injuries, with around 17,810 new cases diagnosed annually. These injuries frequently lead to urinary complications, further driving the need for urinary catheters within this segment.

Overall, the market for urinary catheters is on a steady growth trajectory, driven by the increasing prevalence of urinary conditions, advances in telemedicine, and the critical role of these devices in infection prevention. With ongoing developments in catheter technology and rising awareness of conditions like UI and BPH, the market is poised for continued expansion, particularly in segments related to elderly care and chronic urinary issues.

Order a free sample PDF of the Urinary Catheters Market Intelligence Study, published by Grand View Research.

[indiamedicaltourism]

Liver Cancer Treatment Cost in India

The liver is among the largest organ within the human body. It conducts several essential functions that improve your body's capacity to break down food, absorb vitamins and minerals, and repair injuries. The liver is positioned near the ribs on the right-hand side of your abdomen. It is the source of bile, a fluid that helps break down fats, vitamins, and other minerals.

When liver cancer forms, it damages liver cells and disrupts the liver's capacity to function effectively.

Primary and secondary are the two types of liver cancer. In the liver's cells, primary liver cancer starts to develop. When cancer cells of a different organ move to the liver or are advanced, secondary liver cancer arises.

Cancer cells can split from their starting location compared to other cells in your body. By passage of the lymphatic or circulatory systems, the cells could travel to other parts of your body. Cells can begin to multiply once they get to other organs or tissues.

The level (stage) of the medical conditions, along with your health status, age, and choices, all impact how you receive treatment for liver cancer. If your tumor is miniature and the functioning of your liver is excellent, the doctor could often recommend surgery to remove the cancerous liver tissue and just a fraction of adjacent healthy liver tissue.

Liver Cancer Treatment cost in India

The beginning cost of Liver Cancer Treatment in India is ₹200000. The expense of liver cancer treatment typically fluctuates across hospitals and medical facilities depending on several variables. The median expense for treatment of liver cancer is ₹2,75,000. The price variation can reach as high as ₹3,50,000. Several factors influence the cost of liver cancer treatment. Examine the key elements that affect the price of Liver Cancer Treatment in India:

Consultation Charge

Diagnostic Evaluations for Liver Cancer Surgery

Kind of Surgery

Condition of the Patient

Age of the Patient

Kind of Hospital

Category of Room selected

City or place

Best Liver Cancer Treatment Hospitals in India

The best Liver Cancer Treatment hospital in India gets NABH and JCI recognition certified. It means the hospital preserves outstanding medical standards for its patients. You could also find out if the hospital provides adaptable surgical facilities that satisfy global requirements. To treat liver medical conditions, choosing a hospital with modern technology and sophisticated monitoring systems is essential. The best hospital for Liver Cancer Treatment in India has an unblemished liver care record and is highly recommended for difficult liver treatments.  Kokilaben Dhirubhai Ambani Hospital, Medanta Hospital and Fortis Escorts Heart Institute are among the best hospitals.

Best Liver Cancer Treatment hospitals in India

In India, there are several trained and qualified doctors with a specialization in treating liver cancer. The following are a few of the Best Doctors for Liver Cancer Treatment in India:

Suma Sethumadhavan Nair, MD, of Medanta the Medicity Hospital

Dr. Shekhar Patil of the Bangalore-based HCG Cancer Centre

Dr. Suresh Advani of Nanavati and Jaslok Hospital

Al Afiya Medi Tour is a leading medical tourism company in India. We are offer medical tourism services in India foreign patients. Some of the main countries are Bangladesh, south Africa, Uganda, Zambia, Namibia, Iraq, Kenya, Nigeria and so on. We provide free assistance for TURP surgery cost in India, lung cancer treatment, stomach cancer treatment in India, liver transplant cost in India, best hospital for heart valve replacement, bone marrow transplant cost in India, arthroscopic surgery, best liver transplant hospital in India, brain tumor surgery cost in India, kidney transplant in India, liver cancer treatment,best bone marrow hospital in India etc.  If you are searching for free medical and healthcare consulting to find the best hospitals and top doctors and surgeons in India for any treatment then contact us- Alafiyameditour.com.

Source: https://bestmedicaltourismcompanyinindia.blogspot.com/2023/09/liver-cancer-treatment-cost-in-india.html

[ameymeti2001]

Bone Growth Stimulator Market Worth 1,397.6 Million USD By 2022

The global Bone growth stimulator market will grow at a CAGR of 5.8% during the forecast period to reach USD 1,397.6 million by 2022, according to the latest publication from Meticulous Research®. The bone growth stimulator market driven by growing geriatric population with the prevalence of orthopaedic issues and rising preference for stimulation treatments. Moreover, emerging economies such as Latin America, Asia, and Africa provides significant opportunities in this market. However, complications associated with the use of bone morphogenetic proteins (BMP) and unfavorable reimbursement scenario related to bone growth stimulators hinders the growth of the market to some extent.

The global bone growth stimulator market is mainly segmented by product, (bone growth stimulation devices, bone morphogenetic proteins, and platelet rich plasma), by application, (spinal fusion surgeries, delayed union & non-union fractures, oral and maxillofacial surgeries, and others), by end user (hospitals & clinics, academic and research institutes, contract research organizations, and home care), and geography.

Based on product type, bone growth stimulation devices held the largest share of the market in 2016 and expected to continue its dominance in the global bone growth stimulator market during the forecast period, owing to rising adoption of external & implanted stimulators for the accurate treatment therapy with increasing incidence & prevalence of orthopedic problems with aging population, growing need for cost effective & easy accessible medical devices, rising number of road accidents & trauma, reducing complications associated with bone surgeries, and increasing secondary diseased conditions such as obesity & diabetes.

On the basis of application, spinal fusion surgeries held the largest share in the global bone growth stimulator market in 2016. This was mainly attributed to rising number of spine procedures with increasing risk of orthopedic problems, increasing bone related injuries by growing number of road accidents, trauma and sport activities, growing pain from degenerative disc disorder with instability, and rising adoption of bone growth stimulation products due to decreasing normal bone healing process with increase in the age.

Based on end user, hospitals & clinics commanded the largest share in 2016 due to continuous increase in the number of spinal fusion and orthopedic surgeries performed in the hospital settings, and related increase in the demand for bone growth stimulators from these healthcare organizations to enhance the bone healing process of their patients.

                                                    𝘿𝙤𝙬𝙣𝙡𝙤𝙖𝙙 𝙎𝙖𝙢𝙥𝙡𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 -                                         https://www.meticulousresearch.com/download-sample-report/cp_id=3530

Geographically, this market is segmented into North America (U.S. and Canada), Europe (Germany, France, Italy, Spain, U.K., Turkey, and RoE), Asia Pacific (China, India, Japan, Indonesia, South Korea, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share in the global bone growth stimulator market in 2016, followed by Europe and Asia-Pacific. The large share of this market is mainly attributed to remarkably advanced healthcare industry with higher healthcare spending and adoption of innovative science & technology; increasing prevalence & incidence of orthopedic diseases such as osteoarthritis, chronic back & neck pain, rheumatoid arthritis, and others with expanding proportion of elderly population; availability of research funding; and growing focus on improving treatments. However, Asia Pacific and Latin America regions are expected to witness significant growth during the forecast period due to demographic transition from high fertility & mortality to low fertility & mortality, accelerated growth of economies, lower regulatory hurdles, remarkable advances in science & technology; increasing incidence of fractures, osteoporosis, and spinal diseases with aging population; growing patient awareness regarding stimulation treatments; and increasing demand for less invasive therapies in the region.

The key players in the global bone growth stimulator market are Orthofix International N.V. (U.S.), DJO Global, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Johnson & Johnson (U.S.), Stryker Corporation (U.S.), Bioventus Inc. (U.S.), Arthrex, Inc. (U.S.), ISTO Biologics (U.S.), Ossatec Benelux Ltd. (Netherland), Regen Lab SA (Switzerland), ITO CO., Ltd. (Japan), Altis Biologics (Pty) Ltd (South Africa), and Harvest Technologies Corporation (U.S.).

Scope of the report

Market by Product

Bone Growth Stimulation Devices

External Bone Growth Stimulator

Pulsed Electromagnetic Field Devices

Capacitive Coupling Devices

Combined Magnetic Field Devices

Implanted Bone Growth Stimulators

Ultrasonic Bone Growth Stimulators

Bone Morphogenetic Proteins

Platelet Rich Plasma

Market by Application

Spinal Fusion Surgeries

Delayed Union & Non-union Bone Fractures

Oral and Maxillofacial Bone surgeries

Others

Market by End User

Hospitals & Clinics

Academic and Research Institutes

Contract Research Organizations

Home Care

Market by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Turkey

Rest of Europe (RoE)

Asia-Pacific (APAC)

China

Japan

India

Indonesia

South Korea

Rest of APAC (RoAPAC)

Latin America

Middle East & Africa

𝘿𝙤𝙬𝙣𝙡𝙤𝙖𝙙 𝙎𝙖𝙢𝙥𝙡𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 -https://www.meticulousresearch.com/download-sample-report/cp_id=3530

[indiaprdistribution1]

Secondary Care Surgery leader - Pristyn Care grows 5X To open 1000 Surgical Centres in 50 Cities by March ‘22

1.7 million+ patients consulted, now a leader in Secondary Care Surgeries

To facilitate USD 300 million patient financing by FY27

Gurugram, 2021:- Pristyn Care, India’s largest Secondary Care Surgery provider, today announced that it has grown 5 times since January 2021 and aims expansion with 1000+ surgical centres and 50+ cities including doubling the overall employee count by March 2022.

Pristyn Care has emerged as a leading Secondary Care Surgery player in the market in recent times. The company has raised over USD 83 million including USD 53 million in the last round in April 2021, led by Tiger Global and Sequoia among others, and aims to raise the next round at close to USD 100 million.

Commenting on the tremendous growth, Co-Founder Harsimarbir (Harsh) Singh, said “Patient confidence in Pristyn Care has been at an all-time high since the start of the year. Our investment in patient-first processes, onboarding 400+ highly experienced surgeons, expansion to 40 cities & towns, has ensured we are able to serve more patients every year. By March 22, we will reach 1000+ surgical centres and expand to 50+ cities & towns and also double our employee count. Tech being our backbone, 25 percent of the hires will be engineers. Exciting perks and benefits apart from ESOPs are offered to hire the best talent. Our ESOP value has increased 100X since inception and in our last round, we offered a buy-back option for many employees. Future hires will continue to be rewarded above and beyond their salary. More employee-first policies will be announced soon.”

He further added, “Over USD 30 million patient financing has been facilitated since inception and is looking to 10x (USD 300 million) in five years. Getting patients to prioritize their health is our focus and by FY27 we aim to serve 6-8 percent of all the surgery patients in India”

Dr Vaibhav Kapoor, Co-Founder laid out the growth plans till FY27, “In a short time, we have emerged as a leader in Secondary Care Surgeries. We will be the largest Secondary Care Surgery player in the next five years with 2000+ surgical centres and very well-rounded 1500+ experienced surgeons and doctors with an average experience of 15 years and we will operate in 100+ cities & towns. We will continue to invest in the latest medical technology to ensure faster patient recovery. Apart from it, we will build in-house tech to ensure the smoothest surgery experience ever for patients and their families”.

With a 70+ NPS (Net Promoter Score) score, Pristyn Care has differentiated itself by ensuring a 24/7 Personal Care Buddy is allotted to every patient. This coordinator ensures A to Z of surgery - allocating the right doctor to the patient, diagnostics, remote insurance clearance, admission & discharge formalities, patient financing (EMI), and post-surgery doctor consultation - is taken care of. This ensures patients and their family members focus on recovery rather than running around. To encourage preventive healthcare, Pristyn Care is providing free OPD (Doctor Consultation) till December 2021.

Pristyn Care has achieved the title of ‘Centre Of Excellence’ for Laser Piles, Laser Circumcision, Stapler Hemorrhoidectomy, Stapler Circumcision & Cosmetic Laser Gynaecology among others. Supporting the narrative of Indian healthtech, the company has successfully built a network spanning 800+ surgical centers and 400+ experienced surgeons, with an aim to bridge the healthcare accessibility gap in India by offering full-stack surgical healthcare services with patient centricity at the core.

Spotlighted as the top brand advertising on digital in the hospital/clinic category during January to August 2021, Pristyn Care has significantly increased its investment to raise brand awareness. The company recently launched its Surgery Matlab Pristyn Care - TV and Digital Ad campaign with Bollywood actor Hrithik Roshan for the Indian Premier League (IPL) season 2021 and will continue to invest on ICC T20 WC and other channels on TV and digital medium.

About Pristyn Care  

Founded by Harsimarbir (Harsh) Singh, Dr. Vaibhav Kapoor, and Dr. Garima Sawhney in August 2018, Pristyn Care (pristyncare.com) is a leader in Secondary Care Surgeries.

The company has a team of 400+ expert surgeons, performing Surgeries for over 50+ diseases using the latest Advanced Medical technology such as Laser, Laparoscopy, Microdebriders, Lasik, etc. across 800+ Surgical Centres.

It is present in 40 cities and towns viz. Agra, Ahmedabad, Bangalore, Bhopal, Bhubaneswar, Chandigarh, Coimbatore, among others.

Pristyn Care has differentiated itself by ensuring a 24/7 Personal Care Buddy is allotted to every patient. This coordinator ensures A to Z of surgery - allocating the right doctor to patient, diagnostics, remote insurance clearance, admission & discharge formalities, cab pick-up & drop, Free meal for the attendant, Patient Financing (EMI), and Free post-surgery follow-up - is taken care of. This ensures patients & their family members focus on recovery rather than running around.

[smartadmin]

GROWING HEALTH CARE INDUSTRY AND TECHNOLOGY CHANGES IN HEALTHCARE SYSTEM

There are multiple factors which influence the growth of health care system. The growing incidence of lifestyle diseases, ageing population, rising demand of affordable health delivery system, and government initiatives are a few such factors.  It was further influenced by technological changes, and the tax benefits/ incentives in the health insurance.

Technology plays is going to change the overall scenario in the healthcare industry in the coming few years.  Artificial intelligence helps in keeping health records and provides best possible treatment to the patients at right time.  It also helps in guiding in selection of hospitals according to the diseases.  Internet of things helps in asset management and inventory tracking in the hospitals.  Many companies are also working in developing Robotics surgery which will reduce the error of margin in savior surgeries.

The healthcare industry comprises of hospitals, medical tourism, health insurance, telemedicine, clinical trials, pharmaceuticals, and diagnostics (imaging and pathology.  The hospital industry in India accounts to 80% of the total health industry.

The global health expenditure is increasing at a rate of 5.4% from 2017-2022, from $ 7.724 trillion to $10.05 trillion.  The emergence of personalized medicine increases the use of exponential technologies, the demand for expanded care delivery sites, and revamped payment and public funding models are all impacting the financial performance of the health care ecosystem.

The private sector has emerged as a vibrant force in the healthcare industry in India.  This sector accounts to almost 74% of the total health expenditure in India.  By 2020 India will become the top 3 health care market in terms of growth.  Health care has become the one of the largest sectors in terms of revenue and employment.  In 2017, the sector employed a total of 319,780 people in India.  According to market estimates, the hospital industry will reach $132 billion by 2023, from $61.8 billion in the year 2019 with growing at a CAGR of 17%.  The medical tourism in India is $3 billion in 2017.  The government has launched Ayushman Bharat National Health protection Mission, through this initiative the government will provide Rs5 lakh per family per year for secondary and tertiary care hospitalization, allocation of $887.04 for AB-NHPS under the union budget 2019-2020

The US healthcare spending in the US will reach $5.7 trillion in 2026, which is around 19% of the total US economy in 2016, according to the data published by Reuters.  The U.S. healthcare information technology (HCIT) market generated $61.01 billion in 2017, and is projected to reach $149.17 billion by 2025, growing at a CAGR of 11.7% from 2018 to 2025.

[blogsurajus]

Veterinary Electrosurgery Market Latest Trend and Future Scope with Top Key Players 2021-2026

Veterinary Electrosurgery Market 2021-2026 The Global Veterinary Electrosurgery Market involves an ideal combination of primary and secondary research with the help of which the experts’ inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability.

The Major Players Covered in this Report: Braun Melsungen AG (Germany) Boston Scientific Corporation (the U.S.) Coloplast Ltd. (Denmark) ConvaTec Inc. (the U.K.) Becton, Dickinson and Company (the U.S.) Cardinal Health (the U.S.) Teleflex Incorporated (the U.S.) Wellspect HealthCare (the U.S.) Degania Silicone Ltd. (Israel) Medical Technologies of Georgia (the U.S.) ROCAMED (Monaco) Well Lead Medical Co., Ltd. (China) Go Medical Industries Pvt. Ltd. (Australia) MANFRED SAUER GMBH (Germany) Ribbel International Limited (India).

Get a Sample PDF Report: https://straitsresearch.com/report/Veterinary-Electrosurgery-market/request-sample

By Product

Indwelling Catheters Intermittent Catheters External Catheters By Type

Coated Catheters Uncoated Catheters By Usage

Male Urinary Catheters Female Urinary Catheters By Application

Urinary Dysfunction Spinal Cord Injury General Surgery Benign Prostatic Hyperplasia Parkinson’s Disease Other Applications By End-User

Hospitals Clinics Long-Term Care Facilities Other End Users

The report specifically highlights the Veterinary Electrosurgery market share, company profiles, regional outlook, product portfolio, a record of the recent developments, strategic analysis, key players in the market, sales, distribution chain, manufacturing, production,  new market entrants as well as existing market players, advertising, brand value, popular products, demand and supply, and other important factors related to the Veterinary Electrosurgery market to help the new entrants understand the market scenario better.

Important factors like strategic developments, government regulations, Veterinary Electrosurgery market analysis, end-users, target audience, distribution network, branding, product portfolio, market share, threats and barriers, growth drivers, latest trends in the industry are also mentioned.

Regional Analysis For Veterinary Electrosurgery Market:

North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the Veterinary Electrosurgery are as follows:

• History Year: 2014-2019 • Base Year: 2019 • Estimated Year: 2020 • Forecast Year 2021 to 2026 The main steps in the investigation process are:

1) The first step in market research is to obtain raw market information from industry experts and direct research analysts using primary and secondary sources.

2) Extracts raw data from these sources to extract valuable insights and analyze them for research purposes.

3) Classify the knowledge gained by qualitative and quantitative data and place it accordingly to make final conclusions.

Key Questions Answered in the Report:

• What is the current scenario of the Global Veterinary Electrosurgery Market? How is the market going to prosper throughout the next 6 years? • What is the impact of COVID-19 on the market? What are the major steps undertaken by the leading players to mitigate the damage caused by COVID-19? • What are the emerging technologies that are going to profit the market? • What are the historical and the current sizes of the Global Veterinary Electrosurgery Market? • Which segments are the fastest growing and the largest in the market? What is their market potential? • What are the driving factors contributing to the market growth during the short, medium, and long term? What are the major challenges and shortcomings that the market is likely to face? How can the market solve the challenges? • What are the lucrative opportunities for the key players in the Veterinary Electrosurgery market? • Which are the key geographies from the investment perspective? • What are the major strategies adopted by the leading players to expand their market shares? • Who are the distributors, traders, and dealers of the Global Veterinary Electrosurgery market? • What are sales, revenue, and price analysis by types and applications of the market? For More Details On this Report: https://straitsresearch.com/report/Veterinary-Electrosurgery-market

About Us:

Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs. Moreover, we're continually developing, not only with regards to where we measure, or who we measure but in how our visions can enable you to drive cost-effective growth.

Contact Us:

Company Name: Straits Research Email: sales@straitsresearch.com Phone: +1 646 480 7505 (U.S.) +91 8087085354 (India) +44 208 068 9665 (U.K.)

[mangeshp7793]

What Impacted COVID-19 on Medical Second Opinion ?

Impact of COVID-19 on Medical Second Opinion in Healthcare Industry

New coronavirus disease outbreak (COVID-19) in 2019 caused by extreme acute respiratory coronavirus-2 syndrome (SARS-CoV-2) has posed a significant threat to the population and has a huge effect on the economy, GDP and industry worldwide. The World Health Organization (WHO) has announced that the pandemic of COVID-19 has a high transmission rate that threatens many lives. The association of the Spike-S protein in SARS-CoV-2 with the Ace-2 receptor found in the human lungs is the primary cause for the high transmutability. This is the primary reason or the largest obstacle in the health care sector and perhaps the biggest challenge for healthcare providers in 2020. In December 2019, Chinese health authorities told World Health Organization (WHO) of a mid-serious situation when a group of 40 patients with pneumonia had symptoms, most of them related to the Huanan Sea Food market. Looking at the current situation, China is not suffering from any industry worldwide deficit as the number of graph cases in China is stabilizing. The countries namely the U.S., India, Brazil, Russia and many others around the world are experiencing business decline and a decrease in GDP. Since the declaration of the pandemic, several nations including China, India, the U.S., Russia, Germany and others have entered the full lockdown state in order to minimize the spread of COVID-19 in several countries such as China, New Zealand and South Korea which have succeeded due to their tight laws and increased monitoring and the Chinese company Baidus has begun heat mapping which has made testing simpler.

According to the weekly epidemiology report of 9th February 2021 by World Health Organization (WHO) stated 3.1 million cases of coronavirus has been reported globally in past week, this brings to over 105.4 million reported cases and over 2.3 million patients are dead due to the coronavirus globally. The outbreak of COVID-19 is having a huge impact on the healthcare industry which also means need for medical second opinion because of the growing concern of patients.

The second medical opinion is the type of service or supplemental consultation that the patient gets following their primary diagnosis. After that, the patient may get a second medical opinion if the patient is displeased with the diagnosis or if more information is required in the case of any critical surgical procedures. There has been a recent rise in medical second opinion providers largely due to clinical, financial and legal risks associated in care. As we say “Second Opinions: Two Heads are better than one”. Because of the contagion nature of COVID-19 and the rising number of pandemic events and various new diseases, a second opinion is very common and encouraged by doctors. So, the demand for second opinion market has increased though the growth is anticipated to be increased at a higher pace then it is now but due to pandemic and lockdown globally, the growth was subdued. It has also been forecasted by research analysts that after pandemic, this growth will further increase due to COVID-19, people are now more conscious about their health, further more increasing prevalence of peripheral vascular disorders and growing importance on superior treatment outcomes, rising inclination for healthcare cost optimization and increasing prevalence of diseases due to change in lifestyle, growing number of hospitals all over the world are also expected to fuel medical second opinion market. Due to COVID-19, on the basis of disorders, cancer and especially (lung cancer) patients have been at the front position of using the technology (tele-medicine) to manage their diagnosis for years, also with growing concern of people cardiac disorders, diseases related to respiratory system and surgical interventions are going to get huge revenue in future. Apart from that, organ transplant opinion by primary doctor make patient concerned and in-turn patient will look for medical second opinion and increases the revenue.

IMPACT ON SUPPLY

The bulk of the consumer supply has been affected due to COVID-19. The lockdown imposed by many countries is the key reason why imports and exports for many markets have been slowing down. The medical second opinion market is extremely fragmented and the key players have used different tactics such as expansions, creative solutions, joint ventures, alliances, collaborations, acquisitions and others to expand their presence in the market.

Although, the ease of use, relatively low cost of doctor's telephone consultations and the ubiquity of smartphones make this an attractive option for monitoring patients and identifying problems at an early stage, there are important considerations with these devices that patients and providers may not be aware of the potential to have an impact on the successful implementation of such a monitoring programme.

These technologies as tele-medicine and online prescription are not halted during the pandemic and serve as a boon technology for human beings based on software’s and A.I., so the technology relies on the vast supply of medical case data to train the machine model, for that, machine learning and deep learning is utilized, this is done to train it’s algorithms and to find the patterns in the images and identify specific anatomical markers. Also to keep the vast amount of data stored, big data is needed. Medical reports and data can be transferred in the form of pdf, images and others. So accessibility for medical records were easy, only thing that was halted is to perform diagnosis tests as they were carried out in hospitals and reaching to hospitals during the pandemic time was not so safe.

For instance,

·         To keep the track of patient SpO2 measurement, we need to first train the model by using training data of a fit individual collected from various databases, hospitals data, surveillance and others. After that we can provide the tested data to machine which then provide us accurate results.

Via a detailed study of trends in a given digital image, imaging algorithms may produce metrics and outputs that fit radiologist analyses which can be useful for rapid diagnosis.

Supply of the data is somewhat complicated by COVID-19 owing to a worldwide lockout, quick access to hospital data is not necessary to train the machine learning algorithm and without that artificial intelligence cannot be applied. Supply chain for data is broken but this is not entirely so because much of the patient data is stored on cloud servers or databases, one may still approach officials and purchases the data, many websites such as Kaggle and github are instances that store data and are easily available to everyone. Also tele-medicine and online consultations helps a lot and their supply chain of data in the form of images or pdf was not hampered.

Better and increasing numbers of diagnostic procedures carried out is expected to drive the medical second opinion market growth and supply for new solutions

The capacity and performance of customized care, better treatments and treatment of patients is also expected to fuel development in the demand for portable physical exercise products such as SpO2 and bpm fit-bands and smartwatches, although measurement also improves the supply of second opinion medical devices. On the other hand, some restraints are:

·         Rising lack of awareness

·         Reluctance toward opting for medical second opinion in emerging nations

·         Frequent changes in the economic status of developing countries

·         Also, providing tele-medicine facilities in the under-developed nations can be challenging

·         High cost and reluctance of adoption of these systems

·         Due to COVID-19, easy accessibility of data from hospitals to train machine learning model is not possible

IMPACT ON DEMAND

The global market for medical second opinion market is mainly related to the high prevalence of the cardiovascular disease, high rate of obesity, major surgical advices, lungs & respiratory tract disorders and the growing need for minimally invasive procedures. Additionally, factors such as increased number of tough healthcare decisions, expensive tests are right or not and risky surgery and finally unsure about the diagnosis, government initiatives and support, increased demand for advanced treatments, research and increased clinical trials for new diseases and increasing players that are offering newer solutions will probably stimulate the market. Tele-medicine and online second opinion become lucrative to increase the demand during the COVID-19 pandemic and will remain be a boon technology in future. This technology has by this time already demonstrated there efficacy, accuracy and refinement of results, that’s why researchers, physicians and pathologists know the value of the technology and hence, they are looking to hasten their productivity and potentially improve their accuracy in diagnosis of clinical abnormalities and problems related with patients.

Furthermore, accruing proof suggests that a sub-group of patients with severe COVID-19 acute respiratory distress syndrome (ARDS) with hypoxemia might have cytokine storm syndrome. Certainly, 25–31% of COVID-19 patients displayed irregular blood clotting. Blood clots can break apart and lodge in the pulmonary organs as lungs, causing in pulmonary embolism, while clots from arteries can lodge in the brain, triggering stroke. While the lungs are “ground zero”, clots can form in organ systems from the brain to blood vessels. This is a major reason for the increasing concern in patients to look for secondary option to treat the disorder or preventive measures against the virus.

Additionally, it has been found in the study of direct SARS-CoV-2 infection of endothelial cells and diffuse endothelial inflammation. Subsequently, SARS-CoV-2 targets blood vessels, patients with pre-existing damage to those vessels such as from diabetes and high blood pressure, face a higher risk of serious disease as hematological blood disorders, this is another main dynamic factor powering the market growth presently by multiple biotechnological and pharmaceutical companies globally to accelerate drug or vaccine development processes for the COVID-19.

Global medical second opinion market is expected to gain market growth and not just because of COVID-19, although the impact of COVID-19 has increased the growth of the market but the demand for medical second opinion was also higher in the period of 2015-2020 due to increasing number of geriatric, diabetic and cardiovascular diseases, although it is not as high as it is now. Because of the COVID-19, a new respiratory disorder with lots of mystery, it is clear that after COVID-19 pandemic will get over, it will further boost the global medical second opinion market because of the awareness in people about diseases and the increasing concern for physical care. In the pulmonology sector and cardiac sector especially, the demand will be higher. The participation of various start-ups that make some apps and smart tracking devices as fit-bands are also tracking the SpO2 levels which will help in the expansion of blood flow measurement market and become the key factors backing to the growth of the market. The U.S., China and the U.K. are developing as popular hubs for healthcare innovations. Japan and South-Korea also holds the scope for the development of medical second opinion market in healthcare with skilled workers and technologies they possess. Growth in Asia-Pacific is expected to be fast owing to the demand of advanced technologies and increasing cases of cancer, lung cancer, cardiovascular diseases and diabetes. North America rules the medical second opinion market due to highly aware people, innovative healthcare infrastructure, favorable government initiatives and rising prevalence of diseases due to change in lifestyle in the region.

On the other hand, growing healthcare expenditure and amount of hospitals will further boost various opportunities that will lead to the growth of the medical second opinion market. Some companies are launching new products to increase their revenue by meeting the emergent need.

Globally the surge in the demand of medical second opinion market in diagnostics market is going to be observed due to the infectious nature of COVID-19 which could be spread via touch, mucous droplets, use of clothes among others and due to lockdown, the advancement and the pace for development which was expected is likely reduced, but in coming few years, the growth is going to be much higher with increasing awareness of health in people and more accurate results from A.I. and new product launches and smartwatches.         

Some of the applications which can increase the demand for medical second opinion are:

·         Increasing investments in telemedicine technologies

·         Rising modernization

·         Technological advancement in the healthcare sector

·         Rising R&D activities

·         Assessment of auto-regulation capability

KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19

Major competitors currently present in the market are Medisense Healthcare Solutions Pvt. Ltd., Second Opinion International, Cigna, EMS | Elite Medical Services, WorldCare, Medix Staffing Solutions Inc., 2nd.MD, AXA, Medo Asia Sdn Bhd., Medisense, London Pain Clinic, Mondial Assistance, GrandOpinion, Penn Medicine, The Johns Hopkins University, Keio University, Toranomon Hospital and Cleveland Clinic among other domestic and global players.

For instance,

Medisense Healthcare Solutions Pvt. Ltd. as well as all the competitors is now focusing on corona consultation specifically and in turnhelp boosting the revenue for global medical second opinion market.

“During plasma exchange, the plasma of COVID-19 patients is replaced with donated plasma,” explains Maier. “This reduces the viscosity by normalizing the fibrinogen and other factors contributing to the stickiness and potentially may reduce clotting. Still, correlation does not mean causality and we need to study this in large trials to understand whether viscosity is simply a marker of disease or actually contributing to clotting.

Another recent study by Medisense Healthcare solution: “Here's How Night Time Artificial Lights Exposure May Elevate Thyroid Cancer Risk!!”, it states people living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer, suggested the findings of a novel study. These finding comes from a study published early online in 'CANCER', a peer-reviewed journal of the American Cancer Society.

CONCLUSION

The COVID-19 virus is expected to have a long-lasting effect on each business field. The pandemic of COVID-19 forced people to deal with the confusion and regulation of the virus. The virus poses a risk not only to human health but has also created economic hardship and extreme mental pressure, people are losing their jobs and every industry has suffered, causing chaos in everyone's minds. It is now fashioned to wear masks and gloves since COVID-19 has established a modern hygiene method around the world. Although, it cannot be assumed that a second medical opinion is not needed sooner. However, considering the extremely infectious nature of the virus and the ease with which it spreads through droplets or even fomites to some degree, the demand from the medical second opinion and the healthcare sector continues to grow not only for diagnosis but also for R&D to produce a drug or vaccine for the virus. With a spike in the number of cases, countries can also adopt these instruments to track SpO2 amount such as those of South Korea and China in order to keep the number of cases in check. It can be used in diagnostics to provide precise, consistent and accurate results since it is based on a huge and previous amount of data. Patients mostly have their health insurance which is covering for their treatment having a second opinion helps lot in the situation. "Looking to the future, there is clear potential for the medical second opinion consolations & solutions to become mainstream tools in the treatment of COVID-19 patients."

[tmr123123]

Ophthalmic Packaging Market Revenue, Major Players, Consumer Trends, Analysis & Forecast Till 2030

The global ophthalmic packaging market size is predicted to reach at US$ 18.6 billion by 2030 and anticipated to expand at a 10.8% of CAGR over the forecast period 2021 to 2030.

Ophthalmic products are directly administered into the eyes, which make it crucial to pack these products with extreme care to ensure purity and prevention from all physical and chemical contamination. Manufacturers are developing innovative packaging formats to meet the growing need of secure packaging. As an effect, compared with the packaging used by solid oral products, ophthalmic drug packaging is perceived to be comparatively more convenient to the usefulness and safety of the medication. The increasing occurrence of eye-related diseases is the key driver of ophthalmic packaging market.

Increasing global burden of ocular conditions and growing number of ophthalmic clinics, hospitals, and ambulatory care centers are the factors driving the market growth. Additionally, frequent introduction of new drug delivery systems and high demand for advanced packaging solutions is expected to fuel the market during forecast period.

Increasing healthcare expenditure and rising disposable income are some of the prominent factors that are expected to drive a lot of patients towards advanced ophthalmic care. Furthermore, growing number of advanced healthcare facilities such as eye hospitals and ophthalmic clinics across several regions and increasing awareness about preventive care, ocular disorders and self-medications are some of the factors expected to aid to the market growth.

Increasing geriatric population coupled with age related ocular disorders is expected to increase the demand for ophthalmic products. Furthermore, the improving reimbursement policies for ocular surgeries including cataract & eye implants and increasing awareness about ocular disorders and treatment options is expected to drive the market growth.

The government and non-government initiatives such as ocular screening program and national healthcare program is expected to increase the accessibility to ophthalmic healthcare. Furthermore, the initiatives such as “economical free trade zone” & reducing approval time for establishment of facilities will contribute to the establishment of new ophthalmic manufacturing facilities that is expected to increase the demand for the packaging materials over the forecast period.

Dose Insights

Based on dose, the Multiple dose segment held the largest market share in 2020 and expected to grow at a significant rate over the forecast period. The choice of a single dose or multiple dose depends upon various parameters such as the efficacy of the drug, formulation, stability, and the course of treatment. Introduction of smart, patient friendly, and safer multi dose packaging is expected to fuel the segment growth during the forecast period.

Growth of single dose segment can be majorly attributed to high demand for safe medications with minimal or no usage of preservatives. Addition of preservatives increase the final product price. In addition, it may lead to severe allergic reactions. ASEP TECH advantage are the unit dose vials developed by method blow/fill/deal reflected from the development of these preservative free formulations.

Multiple dose dominated the market segment in 2020 and is expected to be the leading segment of the market over the forecast period. Increasing usage of multiple dose packaging systems in OTC preparation coupled with growing prevalence of common ocular disorders such as red eyes, dry eyes and conjunctivitis etc. are the major factors expected to drive the market growth.

Download Research Sample with Industry Insights @ https://www.trendsmarketresearch.com/report/sample/13651

Material Insights

Based on material, the Plastic packaging material accounted for the largest market share in 2020 and is expected to grow at a significant rate over the forecast period. The segment growth is majorly contributed to the advantages associated with plastic material such as inertness, cost efficiency, low weight, and convenience of usage. Low density polyethylene (LDPE) is most preferred type of resins due its flexibility and decreased chances of contamination. In addition, this material is easily recycled, which makes it ideal for single dose containers.

Glass material are traditionally used in pharmaceutical packaging, but they possess some limitations such as brittleness, inconvenience in handling, and high cost; thus is being rapidly replaced by plastic. However, the demand for glass material is still high in formulations with stability and compatibility problems. These formulations include volatile and light sensitive substances. Type 1 borosilicate glass is the U.S. pharmacopeia standard of packaging material for ophthalmic preparations. The segment is expected to face slower growth due to high rate of replacement by advanced plastic options.

Material generally used for liquid ophthalmic preparation is LDPE bottle with a dropper built into the neck and ophthalmic ointments are packaged a metal tube with an ophthalmic. Ointments contents reactive with metal tubes, an epoxy or vinyl plastic coated metal tubes are used. Polyethylene or polypropylene (polyolefin) containers are used for packaging of large volume intraocular irrigation preparations. Increasing focus on usage convenience of the product without compromising on safety of the patients is expected to increase the demand for plastic containers over the years.

Type insights

Based on type, the prescription type held the largest market in 2020 and is expected to grow at significant rate over the forecast period. The largest share is attributable to the factors such as high incidence of ophthalmic disorders and increasing number of ophthalmic clinics, hospitals, and ambulatory care centers.

According to NCBI study, the global burden of eye disease was reported to be 61.4 million worldwide. Improving accessibility to ophthalmic healthcare clinics and development of advance drug delivery systems is expected to foster the growth of prescription type ophthalmic packaging market. Furthermore, people are lot more skeptical when it comes to using an OTC medication for ophthalmic disorders, they generally prefer to visit ophthalmologist to prevent the worsening of condition. Thus, with increasing disposable income and awareness about preventive care more people will consider visiting physicians driving the growth of this market.

OTC type pharmaceutical packaging held a significant market share and is also expected to grow at a steady rate over the forecast period. The growth of this segment can be attributable to the factors such as prevalence of common eye problems including dry eyes and red eyes syndrome. Multiple dose packaging is usually used in OTC type of medication. The growing awareness about self-medication and increasing efforts of people to reduce any future healthcare cost is expected to add to the growth of this segment.

Regional Insights

North America held 40% of the total region wise ophthalmic packaging material market in 2020. Developed R&D and healthcare facilities, rising geriatric population, increasing prevalence of eye disorders and presence of stringent regulatory bodies is expected to drive the market growth. Furthermore, uniform color-coding systems for the caps and labels of all topical ocular medication introduced by the American Academy of Ophthalmology are some of the initiatives expected to fuel the growth.

Europe accounted for the second largest share in ophthalmic packaging market in 2020. Increasing prevalence of age-related ophthalmic diseases such as macular degeneration, diabetic eye diseases, and retinal vein occlusion in Europe has contributed to its share. Furthermore, the factors such as growing presence national eye screening programs and developing ophthalmic care reimbursement policies is expected to propel the growth over the forecast period.

Asia Pacific is projected to grow at fastest CAGR over the forecast period. Developing economies with presence of large patient pool is expected to contribute to this growth especially in regions such as India, China, and Japan. The Indian 2018-19 annual budget emphasize a greatly on “Pharma Vision 2020” aimed to make India a global leader in pharmaceutical manufacturing. Moreover, it has reduced the approval time for the establishment of facilities driving the development of new facilities that would indirectly raise the demand.

Direct Purchase this Market Research Report Now @ https://www.trendsmarketresearch.com/checkout/13651/Single

Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2017 to 2019.

The analysts have provided a comprehensive analysis of the competitive landscape of the global ophthalmic packaging market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation expected to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users) and other segments.

Company Overview

Company Market Share/Positioning Analysis

Product Offerings

Financial Performance

Recent Initiatives

Key Strategies Adopted by Players

Vendor Landscape

List of Suppliers

List of Buyers

Some of the prominent players operating in the global ophthalmic packaging market are Amcor Ltd., Aptar Group., Bemis Healthcare Packaging, Owens-Illinois, Gerresheimer AG, BD, Schott AG, West Pharmaceutical, Alexander (James) Corporation, Westrock and Baxter International.

Market Segmentation

Dose Outlook

Multi dose

Single dose

Type Use Outlook

OTC

Prescription

Material Outlook

Glass

Plastic

Others

Regional Outlook

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

The U.S.

Canada

Germany

UK

France

Italy

Spain

China

Japan

India

Thailand

South Korea

Brazil

Mexico

Argentina

Colombia

South Africa

Saudi Arabia

UAE

This report focuses on ophthalmic packaging market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall ophthalmic packaging market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global ophthalmic packaging market.

Request for Sample with Complete TOC and Figures & Graphs @ https://www.trendsmarketresearch.com/report/requesttoc/13651

The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.

[marketreports-world]

Wolff Parkinson White Syndrome Market - Global Forecast Till 2027

Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global Forecast Till 2027

Market Highlights:

Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than normal heartbeats). WPW is congenital but, symptoms may not become apparent until adolescent. Approximately 10 to 20 percent of individuals with WPW syndrome have a congenital heart defect, such as Ebstein’s anomaly. The disorder’s estimated prevalence is 3 people per 1,000 people in the United States.

The market is driven by advancements in medical devices such as pacemakers and radiofrequency catheter ablation. Product development of these devices in terms of miniaturization of devices and better battery backup is driving the market.

The market drivers for Wolff Parkinson White syndrome are increasing screening for genetic diseases, rising awareness, growing income of people etc. The market restraints are the poor cure rates, poor efficacy and efficiency of effective drugs etc.

Global Wolff Parkinson White Syndrome Market Players

Key players profiled in the report are AngioDynamics, Medtronic, Boston Scientific Corporation, St. Jude Medical, LLC, Abbott, GlaxoSmithKline LLC, Teva Pharmaceutical Industries, Sanofi S.A., and Novartis International AG and others.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4224

Regional Analysis

The Americas which are dominated by the US account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the Wolff Parkinson White syndrome market. The good reimbursement scenario and the greater awareness in the developed regions drive the market.

Europe is the second largest market in the world due to high income and healthcare penetration. The European region is dominated by Germany and France. The presence of large screening programs in the developed regions drives the market for Wolff Parkinson White syndrome.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Wolff Parkinson White syndrome Market” Research Report – Forecast till 2023.

Segmentation

The global Wolff Parkinson White syndrome market has been segmented on the basis of types, diagnosis, treatment and end users.

Based on types, Wolff Parkinson White syndrome has been segmented as type A and type B.

Based on diagnosis, the market has been segmented as Electrocardiogram (ECG), Electrophysiological testing, and others.

Based on treatment, the market has been segmented as drugs, cardioversion, radiofrequency catheter ablation, surgery, artificial pacemaker and others.

Based on the end users, the market has been segmented as hospitals & clinics, academic & research and others.

Table Of Contents

1. Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure

2. Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market Factor Analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

5. Global Wolff Parkinson White Syndrome Market, By Types

5.1 Introduction

5.2 Type A

5.3 Type B

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/wolff-parkinson-white-syndrome-market-4224  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

[alliedmarketresearchs]

In-depth Research on Disposable face Market Business Status, Industry Trends and Outlook 2021 to 2030

Disposable face masks are popular among healthcare professionals who constantly attend to patients or perform surgeries and in consumer avoid the contact of virus and bacteria. The disposable facemasks protect health workers from the mouths of dangerous micro-organisms by damaging aerosols and liquid droplets. These masks, therefore, operate as protective barriers to eliminate or lessen the risk of getting infected. The growing popularity of online shopping platforms is expected to fuel the need for disposable face masks. In this respect, Amazon.com, Inc. and eBay Inc. make a substantial contribution to the supply of goods among the major online players. In addition, the ubiquity of internet sales has created significant demand for disposable designers, particularly for rich consumers throughout the world. With the advent of the COVID-19 pandemic, the requirement for disposable face masks has increased; consumers are using a face mask to stay protected and avoid getting infected by the virus.

Market Scope and Structure Analysis

Ø  Market Size Available for Years

2020–2030

Ø  Base Year Considered

2020

Ø  Forecast Period

2021–2030

Ø  Forecast Unit

Value (USD)

Ø  Regions Covered

North America, Europe, Asia-Pacific, LAMEA

Ø  Segment Covered

Type, Material, Application, Distribution Channel, and Region

Ø  Companies Covered

Kimberly Clark Corporation, Respilon Ltd, Honeywell International Inc, idMask Co, Ltd, Moldex-Metric, Inc, Reckitt Benckiser Group Plc, Respro (UK) Ltd, Flexicare Medical Limited, SunMed LLC, and Timesco Healthcare Limited.

 Get a sample of the report @ https://www.alliedmarketresearch.com/request-sample/12447

COVID-19 Impact Analysis

The     COVID-19 pandemic has led to a huge surge in demand for the disposable     face mask. There is an increase in the need for disposable face mask     supply, both from healthcare professionals and the civil population, for     taking precautionary measures, owing to the rise in the number of COVID-19     cases worldwide.

Manufacturers     of disposable face masks have a chance to capitalize on this increased     demand for medical supplies to ensure an adequate and continuous supply of     face masks in the market. The expansion of the disposable face masks     market is to be affected by the increase in demand.

Top Impacting Factors

High     consumer awareness of airborne diseases has led to a healthy demand for     the product, especially individually. In recent times, there has been a     major contribution to the general public's need for disposable face masks     due to a rise in inflammation of airborne illnesses. A trend that has hit     the market is the increasing use of disposable face masks for personal     use.

The     increasing prevalence of falsified items both on physical and online     platforms is a crucial problem hindering the growth of the disposable face     masks market. The face masks are produced in unsterile sweatshops utilized     for the production of designer trousers or imitation handbags. Many makers     have labeled their items with markings from renowned manufacturers of     medical care, such as 3M, in this respect. These constraints are projected     in the forecast years to limit the market growth.

Market Trends

Exponential growth in healthcare is boosting the growth of the disposable face masks market

In addition to rising public-health concerns, the exponential development of the health centers in recent years has significantly boosted the requirement for the disposable facial mask. According to a WHO report, about 65 million of people worldwide are suffering from COPD; 3 Million of them die every year, the world's third-largest cause of mortality. The above fact contributes to the expansion of the disposable face mask on the market.

New entrants in the market are hindering the growth of the disposable face masks market

Recent outbreaks of viruses and the threat of pandemics are expected to offer high possibilities for both existing and new entrants in the global market for disposable face masks. Local, domestic and small-scale producers that produce bad quality face masks contain factors that are likely to hinder the revenue growth of current companies. The inferior quality of the mask is expected to affect the worldwide disposable face mask sales and revenues of existing players. However, the positive is that these enterprises face several market barriers to original and certified accreditation by the world's qualified and recognized competent regulatory organizations.

Get detailed COVID-19 impact analysis on the Nutritional Food and Drink Market: https://www.alliedmarketresearch.com/request-for-customization/12447?reqfor=covid   

Key Segments Covered

Type

 Type      I

 Type      IIR

 Pleat      Style Mask

 Duckbill/      Chamber Style

 Others

 FFP1

 FFP      2

 FFP      3

Material

Polystyrene

Polycarbonate

Polyester

Cotton

Others

Application

Hospital

Retail

Banking

Travel

Manufacturing

Industrial

Personal

Others

Distribution Channel

Direct     Distribution

Laboratories

Community     Health Center

Retail     Distribution

Hypermarkets/supermarkets

Pharmacies

Convenience     Stores

Online     Retail

Others

Region

 U.S.

 Canada

 Mexico

 Germany

 France

 UK

 Spain

 Italy

 Rest      of Europe

 China

 India

 Japan

 Australia

 South      Korea

 Rest      of Asia-Pacific

 Latin      America

 Middle      East

 Africa

Key Benefits of the Report

This     study presents the analytical depiction of the disposable face masks     industry along with the current trends and future estimations to determine     the imminent investment pockets.

The     report presents information related to key drivers, restraints, and     opportunities along with detailed analysis of the disposable face masks     market share.

The     current market is quantitatively analyzed from 2020 to 2028 to highlight     the disposable face masks market growth scenario.

Porter’s     five forces analysis illustrates the potency of buyers & suppliers in     the market.

The     report provides a detailed disposable face masks market analysis on the     basis of competitive intensity and how the competition will take shape in     coming years

Questions Answered in the Report

Who     are the leading market players active in the disposable face masks market?

What     current trends will influence the market in the next few years?

What     are the driving factors, restraints, and opportunities in the market?

What     future projections would help in taking further strategic steps?

Request a discount on the report @ https://www.alliedmarketresearch.com/disposable-face-masks-market-A12082

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting services to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

[preranajoshi1096]

AI in Computer Vision Market expected to reach USD 70.80 Billion by 2027

AI In Computer Vision Market is valued at USD 4.90 Billion in 2018 and expected to reach USD 70.80 Billion by 2025 with a CAGR of 45.46% over the forecast period.

AI In Computer Vision Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025. Increasing adoption of artificial intelligence in various business verticals, growing demand for mobile edge computing and rising usage of electronic devices are contributing to the growth of the AI in the computer vision market

Scope of AI In Computer Vision Market-

Computer vision is a branch of automation and computer science that allows the perception of machine vision and develops methods for creating systems that gel information from images. It is an interdisciplinary technical field that deals with how computers can increase high-level understanding from digital images or video. Computer vision is a field of artificial intelligence that sequences computers to interpret and understand the visual world. Machines can exactly recognize and locate objects then react to what they “see” using digital images from cameras, videos, and deep learning models. Computer vision is used in controlling processes of industrial robots, in navigations for autonomous vehicles, detecting events, organization information, medical image analysis, automatic inspection in manufacturing processes and Human-computer interactions. Computer vision is closely linked with artificial intelligence, as it provides human vision to a computer. However, a major part of artificial intelligence deals with systems or machines that can perform mechanical work and actions.

Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/1289

* Sample pages for this report are immediately accessible upon request. *

AI in Computer Vision market report is segmented on the basis of type, application and by regional & country level. Based upon type, AI In Computer Vision market is classified into hardware and software. Based upon application, AI In Computer Vision market is classified into healthcare, automotive, agriculture and others.

The regions covered in this AI In Computer Vision market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of AI In Computer Vision is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

AI In Computer Vision Companies:

AI In Computer Vision market report covers prominent players are,

Qualcomm Technologies, Inc.

Google LLC

Allied Vision Technologies GmbH

Basler AG

NVIDIA Corporation

Facebook

Microsoft Corporation

Intel Corporation

Apple Inc.

COGNEX Corporation

Others

Qualcomm Expanded Ecosystem to Enable Next-Gen Edge AI and Machine Learning For Cameras

News: APR 10, 2019, Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated declared nowadays at the International Security Conference & Explanation, broad ecosystem support for the Qualcomm Vision Intelligence Raised area. The ecosystem collaborators have integrated the platforms to deliver powerful computing for edge and on-device camera processing and machine learning, with exceptional thermal efficiency, across a wide range of IoT applications.

AI In Computer Vision Market Dynamics –

The global AI in Computer Vision market is witnessing substantial growth due to increasing adoption of artificial intelligence in various business verticals, growing demand for mobile edge computing and rising usage of electronic devices. According to the IBM report, Edge computing with 5G creates tremendous opportunities in every industry. It carries computation and data storage quicker to where information is formed, enabling better data control, reduced costs, faster insights and actions, and constant operations. In fact, by 2025, 75% of inventiveness data will be managed at the edge, related to only 10% nowadays. However, the insufficient expertise, lack of technical knowledge and security concerns related to the cloud-based image processing is some factors expected to hamper the growth of the market. Moreover, increasing advancement in AI technology and development of machine learning is expected to provide lucrative opportunities for the market player of the AI in the computer vision market.

 AI In Computer Vision Market Regional Analysis –

North America is dominating the AI In Computer Vision market with the potential rate due to owing to the adoption of machine vision across various industries vertical majorly the manufacturing and automotive. According to the International Trade Administration (ITA), The United States has one of the largest automotive markets in the world. In 2018, U.S. light vehicle sales reached 17.2 million units, the fourth straight year in which sales reached or surpassed 17 million units. Generally, the United States is the world’s second-largest market for vehicle sales and production. Additionally, the automotive industry is also at the forefront of innovation. New R&D initiatives are transforming the industry to better respond to the opportunities of the 21st century. According to Auto Alliance, of the $105 billion spent on R&D globally, almost a fifth ($18 billion) is spent in the United States. 

The Asia pacific is expected to emerge as the fastest-growing regional market over the forecast period due to the rising demand for advancement in medical care services in the Asia Pacific market is rapidly increasing the use and adoption of computer vision for accurate and quick medical reports, radiology and, or measuring the blood lost during surgeries, majorly during C-section procedures. According to Healthcare Predictions In Asia-Pacific report, Demand for healthcare in the Asia-Pacific region is growing rapidly. This is especially true given its rising aging population (the number of elderly people in Asia by 2030 will increase by 200 million, or 71 percent) and as governments continue to roll out ambitious universal health coverage schemes. However, Governments and healthcare organizations need constant acceleration in the pace of Asia’s healthcare transformation to address the “silver tsunami” and wide socioeconomic inequality.

Key Benefits for AI in Computer Vision Market Reports –

Global Market report covers in depth historical and forecast analysis.

Global Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global Market report helps to identify opportunities in market place.

Global Market report covers extensive analysis of emerging trends and competitive landscape.

AI In Computer Vision Market Segmentation –

By Type: Hardware, Software

By Application: Healthcare, Automotive, Agriculture, Others

Regional & Country Analysis: North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

Table of Content

1. Chapter - Report Methodology

1.1. Research Process

1.2. Primary Research

1.3. Secondary Research

1.4. Market Size Estimates

1.5. Data Triangulation

1.6. Forecast Model

1.7. USP’s of Report

1.8. Report Description

2. Chapter – Global AI In Computer Vision Market Overview: Qualitative Analysis

2.1. Market Introduction

2.2. Executive Summary

2.3. Global AI In Computer Vision Market Classification

2.4. Market Drivers

2.5. Market Restraints

2.6. Market Opportunity

2.7.  AI In Computer Vision Market: Trends

2.8. Porter’s Five Forces Analysis

2.9. Market Attractiveness Analysis

3. Chapter - Global AI In Computer Vision Market Overview: Quantitative Analysis

4. Chapter – Global AI In Computer Vision Market Analysis: Segmentation By Type

5. Chapter – Global AI In Computer Vision Market Analysis: Segmentation By Application

Full Research Report @ https://brandessenceresearch.com/technology-and-media/ai-in-computer-vision-market-industry-analysis

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com

[decisionforsight]

Global Blood Gas Analyzers (BGA) Market

Global Blood Gas Analyzers (BGA) Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Blood gas analyzer is a blood testing instrument in clinical laboratory which measures hydrogen ions to determine the pressure of carbon dioxide & oxygen present and the amount of acidity in the blood. The body’s oxygen absorption and carrying efficiency is ascertained by the oxygen pressure, while acid elimination efficiency of a body is analysed by the carbon dioxide pressure measurement. In many cases, blood pH level is also determined by BGA. The wide usage of blood gas analyzers in the healthcare sector such as operation rooms, critical care services and emergency department etc. are due to its efficiency in providing with time saving and quick results. The Global Blood Gas Analyzers Market is expected to rise from USD 634.9 million in 2020 to USD 1177.4 million by 2030 at an approx. CAGR of 3.8%. Increasing demand high throughput and integrated systems along with rising old age population in emergency departments and critical care units has made the effect on the widespread usage of BGA across the world. Inclusion of Blood Tests with the provision of blood gas testing can improvise clinical decision-making and patient outcomes in critical care and emergency units.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020181

Market Dynamics and Factors:

Escalating number of chronic diseases (such as cancer, cardiovascular diseases, lung disease) in intensive care units, rising health expenditure for treatment of chronic diseases, increment in demand for integrated combined systems and point-of-care BGA miniaturization are the key factors for the blood gas analyzer market growth. Less skilled laboratory professionals for the complex and difficult-to-use operation of blood gas analyser, high probability of infections owing to the usage of BG Analyser, incorrect procedure for collection of blood from difficult parts of body such as arterial blood are the key factors hampering the market growth in this market. Increment in initiatives of reduction of hospital stays and control & reduction in healthcare spending are the factors which bring in opportunities for market growth/ expansion in this market. Unavailability of skilled laboratory professionals, complex operation of blood gas analyzer and lack of addressal of integrated combined systems are the challenges for the blood gas analyzer market growth.

Market Segmentation:

Global Blood Gas Analyzers Market – By Product Type

Bench Top

Portable  

Global Blood Gas Analyzers Market – By Application 

Anaesthesia

Cardiovascular Surgery

ICU

Diabetes

Blood Vessel Haemorrhage

Drug Overdose

Shock

Others

Global Blood Gas Analyzers Market – By End-User 

Hospitals

Clinics

Ambulatory Surgical Centres

Educational Institutes

Central Laboratories

Point-of-Care

Diagnostic Centres

Global Blood Gas Analyzers Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020181

Geographic Analysis:

Geographically, North America is the dominant region in this market and having large share in the blood gas analyzer market owing to factors such as rising number of product approvals, government initiatives and prevalence of lifestyle diseases. Asia-Pacific is anticipated to be the fastest-growing region in the world with highest CAGR due to factors such as improving healthcare facilities, increasing initiatives of market players, growing patient population base and number of partnerships & joint ventures. Japan, China & India are the largest contributors to the APAC BGA market. European market has been growing significantly with steady market share due to well-developed healthcare infrastructure with increase in the healthcare expenditure in the region.

Competitive Scenario:

The major players operating in the blood gas analyzers market are Siemens AG, Roche Diagnostics Limited, Instrumentation Laboratory of A Werfen Company, Radiometer Medical Aps, Abbott Laboratories Inc., OPTI Medical Systems Inc., Nova Biomedical Inc., Medica Corporation, ERBA Diagnostics Mannheim GmbH, Alere Inc., Samsung Medison, Edan Instruments, Accurex Biomedical Pvt. Ltd.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020181 

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Blood Gas Analyzers (BGA) industry, although key threats, opportunities and disruptive technologies that could shape the Global Blood Gas Analyzers (BGA) Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Blood Gas Analyzers (BGA) Market most.

The data analysis present in the Global Blood Gas Analyzers (BGA) Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Blood Gas Analyzers (BGA) Market business.

The 2021 Annual Global Blood Gas Analyzers (BGA) Market offers:

100+ charts exploring and analysing the Global Blood Gas Analyzers (BGA) Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Blood Gas Analyzers (BGA) Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020181 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[market-research-future]

Ophthalmic Knives Market Key Players, Dynamics, Insights To 2025

Ophthalmic Knives Market Overview

Global ophthalmic knives market is expected to exhibit a strong 4.9% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The report provides a complete overview of the global ophthalmic knives market, including figures and statistics illustrating the market’s growth through the historical review period as well as projections about the market’s likely growth over the forecast period. A detailed overview of the market’s likely growth trajectory over the forecast period is presented in the report. A detailed description of the various segments of the market is also provided in the report in order to provide readers with a granular overview of the market.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8815

Ophthalmic knives are knives used in ophthalmic applications. Ophthalmic knives are used to make deep, fine, and precision cuts during ophthalmic surgeries. The growing demand for ophthalmic procedures is the major driver for the global ophthalmic knives market. Rising prevalence of glaucoma, cataract, keratosis, and other diseases is the major driver for the ophthalmic knives market. Various lifestyle factors, including sedentary lifestyles and overuse of electronic screens, have combined to raise the prevalence of eye diseases in recent years. This has been a major driver for the ophthalmic knives market over the last few years. The increasing prevalence of diabetes has been a major driver for the ophthalmic knives market, as diabetes is closely linked with various ophthalmic disorders and is a causative factor in many eye diseases.

The increasing geriatric population is also a major driver for the global ophthalmic knives market and is likely to remain a major driver for the market over the forecast period and beyond. The geriatric population is more prone than younger demographics to suffer from ophthalmological conditions due to degenerative damage to their eyes. This has driven up the demand for advanced ophthalmological procedures on the elderly. This has been a major driver for the global ophthalmic knives market. The growing geriatric population in emerging markets such as India and China is likely to remain a major driver for the global ophthalmic knives market over the forecast period.

Ophthalmic Knives Market Competitive Analysis:

Leading players in the ophthalmic knives market include Mani Inc., Bausch Health, Diamatrix Ltd., HAI Laboratories Inc., Novartis AG, Sidapharm, Hoya Corporation, Surgical Specialties Corporation, pfm medical ag, Shah Eye Care Pvt. Ltd., Optitech Eyecare, Surgi Edge, Microtrack Surgicals, and Eagle Lab.

Ophthalmic Knives Market Segmentation:

The global ophthalmic knives market is segmented on the basis of product type, utility, blade type, application, end use, and region.

By product type, the global ophthalmic knives market is segmented into crescent knives, slit knives, straight knives, MVR knives, and others. Straight knives comprise the largest segment of the global ophthalmic knives market by product type.

By utility, the ophthalmic knives market is segmented into reusable and disposable ophthalmic knives.

By blade type, the ophthalmic knives market is segmented into diamond, stainless steel, and others such as metal and laser knives. The diamond blade segment is the largest and is likely to retain its dominance over the forecast period due to the superior performance provided by diamond blades.

By application, the global ophthalmic knives market is segmented into cataracts, keratitis, and glaucoma. Cataracts comprise the largest application for the ophthalmic knives market.

By end use, the global ophthalmic knives market is segmented into hospitals, ambulatory surgical centers, and others.

Ophthalmic Knives Market Regional Analysis:

The Americas holds the largest share in the global ophthalmic knives market, followed by Europe and Asia Pacific. The latter is also an important regional market for ophthalmic knives and is likely to exhibit the highest growth rate over the forecast period. The growing prevalence of diabetes and other lifestyle conditions in North America has been the major driver for the ophthalmic knives market in the region, as this has driven the prevalence of various ophthalmological conditions. Increasing awareness about ophthalmological disorders is also an important factor behind the ophthalmic knives market’s growth in North America.

The report takes a look at major developments within the Global Ophthalmic Knives Market amidst the pandemic of the COVID-19 virus. It offers a perspective on the economic scenario and efforts to be taken post the passing of the pandemic.

Table Of Contents

EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Ophthalmic Knives Market, By Product Type

1.1.2. Global Ophthalmic Knives Market, By Utility

1.1.3. Global Ophthalmic Knives Market, By Blade Type

1.1.4. Global Ophthalmic Knives Market, By Application

1.1.5. Global Ophthalmic Knives Market, By End Users

MARKET INTRODUCTION

2.1. Definition

2.2. Scope Of The Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Breakdown Of Primary Respondents

3.5. Forecasting Techniques

3.6. Research Methodology For Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/ophthalmic-knives-market-8815

MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

MARKET FACTOR ANALYSIS

…Continued

Browse Related Research Reports at:

Smart Pills Market Growth Opportunity By Application, Size and Trends

Electric Wheelchair Market Growth Analysis, Size, Global Share and Industry Forecast to 2023

Bioprocess Containers Market | Technology, Trends and Growth Forecast To 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

[asterdmhealthcare]

Frontline Warriors and Volunteers from two Al Warsan isolation facilities honored for helping 1500 Covid-19 patients in Dubai

Around 100 frontline medical professionals, volunteers, government entities and supporting organizations were honored by Aster DM Healthcare and Consulate General of India for their relentless efforts over the last two months which helped in the successful recovery of more than 1500 Covid-19 patients who were asymptomatic or mild to moderately ill…

Aster DM Healthcare and Consulate General of India recognized the efforts of 100 medical professionals, volunteers and representatives of supporting govt. entities in the presence of officials from Dubai Health Authority (DHA).

The 750-bed facility, comprising of two buildings in the Hind Humanitarian City, can be considered as a model isolation facility that saw fast and effective implementation of triage, isolation, quarantine and treatment set-up following all the protocols set-up by DHA, aiding in the recovery of patients.

Dubai, UAE, 25 June, 2020: Around 100 frontline medical professionals, volunteers, government entities and supporting organisations were honoured by Aster DM Healthcare and Consulate General of India for their relentless efforts over the last two months which helped in the successful recovery of more than 1500 Covid-19 patients who were asymptomatic or mild to moderately ill. The Aster Volunteers event saw a special note being delivered by Dr. Azad Moopen- Founder Chairman and Managing Director, Aster DM Healthcare and Shri Vipul- Honorable Consul General of India to UAE and the felicitation was done by Mr. Mohammed Matar- Director, Dubai Health Authority; Ms. Alisha Moopen- Deputy Managing Director, Aster DM Healthcare; Mr. Jobilal Vavachan- CEO, Aster Clinics & Aster Retail and Mr. T.J Wilson- Executive Director & Group Head Governance & Corporate Affairs.

Speaking at the event, Shri. Vipul said, “It has been incredible to witness the highest levels of kindness and collaboration between individuals and organizations during these truly unique and unbelievably challenging times in the recent months. The frontline workers and volunteers have shown real selflessness and persevered against all odds in order to support their local community to fight this pandemic. We are thankful to them, Aster, DHA, Dubai Ambulance, Dubai Police, IBPC, Indian community and everyone involved in the successful delivery of the mandate for this facility.”

“As a healthcare organization, we have been at the forefront of managing this crisis with our facilities and staff being actively involved in working with the government to control the pandemic. Most of the medical staff and volunteers who have been actively involved in managing this facility had volunteered to be a part of this project, putting their own personal safety at risk and they continued to work relentlessly for long hours everyday to be able to heal each of the patients who came to them, following all necessary measures to control the spread of Covid-19. We are proud of their tremendous achievement and commend the work that they have done,” said Dr. Azad Moopen.

Aster Volunteers, the global CSR programme of Aster DM Healthcare, played a crucial role in supporting this facility through the provision of internal and external volunteers who helped with the management of the facility, delivery of treatment protocols, supported by Aster Volunteers Mobile Medical Services team in transferring 450+ positives case to and from various Covid-19 care and isolation facilities in association with Dubai Cooperation of Ambulance Services. This is among the numerous initiatives that had been introduced to help the community cope-up with Covid-19 in UAE like mass screenings in congested areas, free teleconsultation by medical professionals, awareness and educational activities and #FeedTheHungry programme that provided 6707 food and ration kits to people in UAE who have lost their jobs, impacting 300,000 lives in the process. Aster had also dedicated two of its facilities under Aster and Medcare as designated Covid-19 treatment centre in partnership with DHA and brought in 88 medical professionals from its facilities in India to join the Dubai government’s fight against Covid-19.

Three years since its initiation, Aster Volunteers has been able to impact over 2 million lives across different countries through its various initiatives. Today, the programme has 27,000+ active volunteers who are actively involved in driving the programme across many countries.

About Aster Volunteers, the global CSR programme of Aster DM Healthcare

Aster Volunteers programme, the global corporate social responsibility initiative of Aster DM Healthcare, was launched on occasion of the company’s 30th anniversary in 2017 and provides a platform which bridges the gap between people who would like to help with those in need. Driven by Aster DM Foundation, through various initiatives, the programme has been able to impact 2 million+ lives across geographies. Aster Volunteers have been able to treat 290,986 individuals through mobile medical camps; 169,207 people have benefitted from basic life support trainings and 36,019 free surgeries as well as health investigations were conducted; supported with the recruitment of 114 differently abled people and treated 533,146 people through 3,376 medical camps. The aid programme in Somali land, Jordan, Bangladesh and Kerala has benefitted 288,158 people; while 21,302 children have benefitted under Child Health & Wellness initiatives. In the wake of the COVID — 19 pandemic, 816,648 lives have been impacted through screening camps and distribution of food and medical kits. Aster Volunteers have also undertaken 142 initiatives towards Sustainability & Community Connect.

About Aster DM Healthcare

Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in multiple GCC states and is an emerging healthcare player in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare through our hospitals, clinics and pharmacies. We have over 20,000 plus dedicated employees across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands.

For more information about us, please visit www.asterdmhealthcare.com or contact:

Lavanya Mandal

Head of PR and Internal Communications

Aster DM Healthcare

Tel: +971 528126577

Email: lavanya.mandal@asterdmhealthcare.com

Bejoy Changarath

Assistant General Manager — PR & Media Relations

Aster DM Healthcare

Tel: +971 524073559

Email: bejoy.changarath@asterdmhealthcare.com

[marketreports-world]

Patellar Tendinitis Market Research Report - Global Forecast Till 2027

Patellar Tendinitis Market research report: by diagnosis (physical examination, imaging tests) treatment (corticosteroid injection, platelet-rich plasma injection, surgery, medical devices), end user (hospitals & clinics) - Global forecast till 2027

Market Highlights

The people with diabetes and rheumatoid arthritis are more likely to suffer from patellar tendinitis. The patient population suffering from diabetes and rheumatoid arthritis is increasing continuously, which significantly increased the demand for the treatment of the tendinitis drugs. Additionally, adoption of the sedentary lifestyle has fuelled the market growth.

Over the last decade, the total number of hospitals has increased to a great extent, which has influenced the growth of the market positively. Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.

The global patellar tendinitis market is expected to grow at a CAGR of ~8.1% during the forecast period 2017-2023.

Regional Analysis

The Americas patellar tendinitis market is expected to show an extensive growth owing to increasing number of sports injuries, availability of cost-effective treatment, and flourishing growth of the sports medicine. Furthermore, technological advancement in the health care also accelerates the market growth.    

Europe holds the second largest share of the global market. As per the European Union Injury Database, home, leisure, and sports injuries accounted for 73% of all injuries treated every year. It is also stated that sports injuries were common among the population from 10 to 19 years of age. Furthermore, over 7.9 million children under the age of 15 are treated for an injury in European Union (EU) hospitals each year. Out of the total sports injuries, team ball sports account for 40% of all hospital-treated injuries, and the prevalence of sports injuries was found to be higher among men than women. Additionally, In the EU, muscle strains, tendonitis, and stress fracture are the common chronic sports injuries. As per the article published in the Clinics in the Orthopedic Surgery, traumatic tendon injuries are commonly treated sports injuries, especially in the emergency department of the hospital. Additionally, soccer, tennis, indoor ball games, and downhill skiing are various games resulting in Achilles tendon ruptures.  

The Asia Pacific is the fastest growing patellar tendinitis market across the globe. Japan holds a major share of the regional market due to the availability of technology and huge healthcare spending. Rapidly developing the economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.      

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.  

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5134

Segmentation

The global patellar tendinitis market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, it is segmented into the physical examination, imaging tests, and others. An imaging test is further segmented into X-rays, Ultrasound, and Magnetic resonance imaging (MRI).  The treatment segment is divided into corticosteroid injection, platelet-rich plasma injection, surgery, Medical devices, and others. Medical devices are further segmented into the mechanical band, support tape, pre-cut strips, continuous rolls, and others. Based on the end user, it is segmented into hospitals & clinics, research laboratories, and others.

Key Players

Some of key the players in the market are Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/patellar-tendinitis-market-5134

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Nutrigenomics Market Research Report Forecast till 2023

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com